En Es
Categories

Industry News

Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries

By HospiMedica International staff writers
27 Jun 2022

Image: Expanding the role of autonomous robots can mitigate the shortage of physicians (Photo courtesy of Pexels)

An aging population and accompanying retirements will cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage. The healthcare sector is expected to expand rapidly with the decentralization of institutions bringing about more offerings with robotic surgeries. Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.


These are the latest findings of Research and Markets (Dublin, Ireland), a leading market research store.


The adoption of robotic technology has improved the capabilities of surgeons through better ergonomics, motion scaling, and tremor filtration. The need for experience before robotic surgery remains debatable. However, the transition from a laparoscopic surgeon to a robotic surgeon is associated with a shorter learning period. Hence, several medical academic and research institutes in the US and Europe now offer robotic surgery training programs to ensure more surgeons have the required expertise and skills with a shorter learning curve. Hospital spending on capital equipment recorded an upswing early in 2021, signaling a stronger outlook for surgical procedures guided by robotic systems in the coming years. Hospital finances seem to be significantly healthier than they were after the economic downturn following the COVID-19 pandemic onset.


The global RASD market is expected to be driven by increased demand for patient-specific surgeries as well-informed patients are demanding surgeons for personalized therapies and implant procedures. Patients are also demanding maximum comfort while requiring minimum physical supervision. Thus, the focus is shifting to technologies that involve lesser hospital time for patients and lead to quicker recoveries. The need of the hour is reducing surgery times, better efficiencies, and optimized outcomes which can be achieved by robot-assisted surgical devices.


Additionally, the shift toward payments based on quality plus cost over procedure-based reimbursement is likely to change the way medical technologies are evaluated and purchased. These changing reimbursement trends are likely to benefit the global RASD market. Geographically, the RASD market in the emerging economies is expected to grow at a faster pace as large orthopedic participants are focusing on Asia-Pacific and other emerging economies that are projected to grow 2 to 3 times faster than the developed markets.


Related Links:
Research and Markets 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

05 Aug 2022
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Bio-Rad Laboratories (Hercules, CA, USA) has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (Warsaw, Poland) for a total consideration of up to USD 170 million, consisting of approximately USD 100 million in cash, and up to USD 70 million in future milestone payments.
Read More
04 Aug 2022
Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure
The global capsule endoscopy system market is expanding at a rapid pace due to the rising demand for the procedure using minimally invasive diagnostic techniques, increase in the introduction of technologically advanced capsules, growth in the geriatric population, and rising prevalence of cancer around the world.
Read More
02 Aug 2022
PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics
PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.
Read More
31 Jul 2022
Labcorp to Spin Off Clinical Development Business
LabCorp Diagnostics (Burlington, NC, USA) has announced that its board of directors has authorized the company to pursue a spin-off of its wholly owned Clinical Development business to shareholders through a tax-free transaction.
Read More
31 Jul 2022
IFCC Celebrates 70 Years of Advancing Science of Laboratory Medicine and In Vitro Diagnostics
The IFCC is celebrating 70 years (1952 – 2022) of enormous achievements that have been extraordinary and impressive, contributing to its mission of “Advancing excellence in laboratory medicine for better healthcare worldwide”.
Read More
27 Jul 2022
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Informa Markets (London, UK), in partnership with Impact Muang Thong Thani (Nonthaburi, Thailand), have confirmed that Medlab Asia and Asia Health will take place in Thailand for the first time when the co-located events return live and in-person at the Impact Exhibition Center, Bangkok, from 19-21 October 2022.
Read More
25 Jul 2022
Registration Opens for RSNA 2022
Registration is now open for the Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) 108th Scientific Assembly and Annual Meeting to be held at McCormick Place Chicago, Nov. 27 – Dec. 1, 2022.
Read More
25 Jul 2022
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) and ELITechGroup S.p.A. (Puteaux, France) have entered into a strategic partnership for monkeypox virus testing across Europe.
Read More
20 Jul 2022
GE's Healthcare Business to Be Named GE HealthCare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions